Ryvu Therapeutics Logo

Ryvu Therapeutics

🇵🇱
RVU
PLSELVT00013

Ryvu Therapeutics is a publicly listed Polish biotechnology company based in Kraków. It discovers and develops small-molecule drug candidates for oncology, advancing novel cancer therapies through early-stage clinical research.

Next Quarterly Earnings

Thursday, September 10, 2026
CW 37
Pre-Market
In 14 days

Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

Currently in quiet period until September 10, 2026

Stock Price

Frequently asked questions

When will Ryvu Therapeutics report its next quarterly earnings?

Ryvu Therapeutics is scheduled to report its next quarterly earnings on 09/10/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).

How do I add the Ryvu Therapeutics earnings dates to my calendar?

Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.

All Dates

Q2 2026
Estimate:-PLN 4.39
Actual:
Q3 2026
Estimate:
Actual:

Company Information

Name
Ryvu Therapeutics
Ticker Symbol
RVU
ISIN
PLSELVT00013
Country
🇵🇱
Poland
Sector